dday1,
You are predicting Relenza market share is moving to 50%, of the antiviral sales, can you explain why Relenza market share actually dropped in the last quarter?
Biota said that too but the facts from the sales figures show a different picture.
Minor details? Sales figures do not lie.
Add to My Watchlist
What is My Watchlist?